Citigroup

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
Manager Name
Citigroup
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions • $44.8B total value
Manager:
Search and click to pin securities to the top
Page 233 of 239
98980W107
Shares:18
Value:$133
% of Portfolio:0.0% ($133/$44.8B)
KOSS CORP
Shares:28
Value:$132
% of Portfolio:0.0% ($132/$44.8B)
G52441105
Shares:5
Value:$125
% of Portfolio:0.0% ($125/$44.8B)
GCT Semiconductor Holding, Inc.
Shares:74
Value:$121
% of Portfolio:0.0% ($121/$44.8B)
US ENERGY CORP
Shares:98
Value:$118
% of Portfolio:0.0% ($118/$44.8B)
Upland Software, Inc.
Shares:39
Value:$112
% of Portfolio:0.0% ($112/$44.8B)
Bridger Aerospace Group Holdings, Inc.
Shares:98
Value:$111
% of Portfolio:0.0% ($111/$44.8B)
G57Y3D109
Shares:16
Value:$111
% of Portfolio:0.0% ($111/$44.8B)
Critical Metals Corp.
Shares:77
Value:$107
% of Portfolio:0.0% ($107/$44.8B)
International General Insurance Holdings Ltd.
Shares:4
Value:$105
% of Portfolio:0.0% ($105/$44.8B)
Cango Inc.
Shares:27
Value:$102
% of Portfolio:0.0% ($102/$44.8B)
Dingdong (Cayman) Ltd
Shares:36
Value:$97
% of Portfolio:0.0% ($97/$44.8B)
Q32 Bio Inc.
Shares:58
Value:$96
% of Portfolio:0.0% ($96/$44.8B)
ADAMS DIVERSIFIED EQUITY FUND, INC.
Shares:5
Value:$95
% of Portfolio:0.0% ($95/$44.8B)
Co-Diagnostics, Inc.
Shares:294
Value:$91
% of Portfolio:0.0% ($91/$44.8B)
83425V104
Shares:530
Value:$89
% of Portfolio:0.0% ($89/$44.8B)
78463X749
Shares:2
Value:$87
% of Portfolio:0.0% ($87/$44.8B)
025072877
Shares:1
Value:$87
% of Portfolio:0.0% ($87/$44.8B)
Predictive Oncology Inc.
Shares:54
Value:$82
% of Portfolio:0.0% ($82/$44.8B)
Lulu's Fashion Lounge Holdings, Inc.
Shares:205
Value:$82
% of Portfolio:0.0% ($82/$44.8B)